Back
Cytokinetics Stock Predictions
Sponsored
CYTK
Sponsored
Yours Free! Top SIX AI Dividend Stocks Right Now
NO CREDIT CARD REQUIRED!
Sell
49
CYTK
Cytokinetics
Last Price:
55.63
Seasonality Move:
12.68%
7 Day Trial
ALL ACCESS PASS
$
7
U.S. Government Report Alert Tuesday
Discover the Secret LoopholeCytokinetics Stock Forecast
- Over the next 52 weeks, Cytokinetics has on average historically risen by 13.6% based on the past 20 years of stock performance.
- Cytokinetics has risen higher in 11 of those 20 years over the subsequent 52-week period, corresponding to a historical accuracy of 55%
-
Is Cytokinetics Stock Undervalued?
The current Cytokinetics [CYTK] share price is $52.52. The Score for CYTK is 49, which is 2% below its historic median score of 50, and infers higher risk than normal. - CYTK is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
Will Cytokinetics Stock Go Up Next Year?
- Over the next 52 weeks, Cytokinetics has on average historically risen by 13.6% based on the past 20 years of stock performance.
Cytokinetics Stock Rating
Sell
49
Cytokinetics (CYTK)
is a Sell
Is Cytokinetics overpriced?
- Cytokinetics has risen higher in 11 of those 20 years over the subsequent 52-week period, corresponding to a historical accuracy of 55%
Cytokinetics Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
cytokinetics.com
52-Week Data
52-Week High:
110.25
52-Week Low:
30.68
Prediction Charts
Market Cap:
6.18B
Price in USD:
52.52
Volume:
1.14M
Beta:
1.44
Technical Analysis
SMA50:
54.14
SMA100:
54.88
SMA200:
61.30
52-Wk Change:
44.6%
Stock Predictions
-
Is Cytokinetics stock public?
Yes, Cytokinetics is a publicly traded company. -
What is the Cytokinetics stock quote today?
The Cytokinetics stock price is 52.52 USD today. -
How to buy Cytokinetics stock online?
You can buy Cytokinetics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
Date | Opening | Closing | Minimum | Maximum |
---|---|---|---|---|
Oct-16 | 56.10 | 55.28 | 56.10 | 54.59 |
Oct-18 | 54.45 | 54.97 | 55.15 | 54.07 |
Oct-21 | 54.50 | 53.81 | 54.85 | 53.15 |
Oct-22 | 53.75 | 54.94 | 55.14 | 53.50 |
Oct-23 | 54.65 | 53.04 | 54.95 | 53.01 |
Oct-24 | 53.05 | 52.40 | 53.82 | 52.06 |
Oct-25 | 52.56 | 51.32 | 53.31 | 51.24 |
Oct-28 | 52.25 | 52.26 | 53.32 | 52.04 |
Oct-29 | 51.92 | 51.51 | 52.24 | 51.19 |
Oct-30 | 50.93 | 51.37 | 52.07 | 50.93 |
Oct-31 | 51.04 | 51.05 | 51.47 | 50.53 |
Nov-1 | 51.61 | 51.82 | 52.37 | 51.02 |
Nov-4 | 51.35 | 51.48 | 52.10 | 50.97 |
Nov-5 | 51.31 | 52.52 | 53.00 | 50.88 |
Cytokinetics Earnings
Cytokinetics Earnings Report: Per Share Cytokinetics Earnings Q1 Q2 Q3 and Q4 last year and next year.
Cytokinetics Forecast Revenue Growth
Cytokinetics Stock Analysis: Historical quarterly revenues per share for Cytokinetics and historical quarterly revenue growth:
- Analysts estimate an earnings decrease this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.28 per share, and an increase next year of $0.22 per share.
* Cytokinetics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.